Lung Cancers Completed Phase 1 Trials for Irinotecan (DB00762)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00346801CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT00132054Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerTreatment
NCT00062322Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerTreatment
NCT00052494Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00059761Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerTreatment
NCT00045604Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00022308Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerTreatment
NCT00004095Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment